200 related articles for article (PubMed ID: 37062071)
1. Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival.
Soares KC; Jolissaint JS; McIntyre SM; Seier KP; Gönen M; Sigel C; Nasar N; Cercek A; Harding JJ; Kemeny NE; Connell LC; Koerkamp BG; Balachandran VP; D'Angelica MI; Drebin JA; Kingham TP; Wei AC; Jarnagin WR
Cancer Med; 2023 Jun; 12(11):12272-12284. PubMed ID: 37062071
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma.
Franssen S; Soares KC; Jolissaint JS; Tsilimigras DI; Buettner S; Alexandrescu S; Marques H; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Margonis GA; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Marsh JW; Cercek A; Kemeny N; Kingham TP; D'Angelica M; Pawlik TM; Jarnagin WR; Koerkamp BG
JAMA Surg; 2022 Jul; 157(7):590-596. PubMed ID: 35544131
[TBL] [Abstract][Full Text] [Related]
3. The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases.
Buisman FE; Galjart B; van der Stok EP; Kemeny NE; Balachandran VP; Boerner T; Cercek A; Grünhagen DJ; Jarnagin WR; Kingham TP; Verhoef C; Koerkamp BG; D'Angelica MI
HPB (Oxford); 2020 Sep; 22(9):1271-1279. PubMed ID: 31889627
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma.
Franssen S; Holster JJ; Jolissaint JS; Nooijen LE; Cercek A; D'Angelica MI; Homs MYV; Wei AC; Balachandran VP; Drebin JA; Harding JJ; Kemeny NE; Kingham TP; Klümpen HJ; Mostert B; Swijnenburg RJ; Soares KC; Jarnagin WR; Groot Koerkamp B
Ann Surg Oncol; 2024 Jan; 31(1):115-124. PubMed ID: 37814188
[TBL] [Abstract][Full Text] [Related]
5. Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.
Konstantinidis IT; Groot Koerkamp B; Do RK; Gönen M; Fong Y; Allen PJ; D'Angelica MI; Kingham TP; DeMatteo RP; Klimstra DS; Kemeny NE; Jarnagin WR
Cancer; 2016 Mar; 122(5):758-65. PubMed ID: 26695839
[TBL] [Abstract][Full Text] [Related]
6. Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
Holster JJ; El Hassnaoui M; Franssen S; IJzermans JNM; de Jonge J; Mostert B; Polak WG; de Wilde RF; Homs MYV; Groot Koerkamp B
Ann Surg Oncol; 2022 Sep; 29(9):5528-5538. PubMed ID: 35294656
[TBL] [Abstract][Full Text] [Related]
7. Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma.
Sebastian NT; Tan Y; Miller ED; Williams TM; Noonan AM; Hays JL; Abdel-Misih S; Diaz DA
JAMA Netw Open; 2019 Sep; 2(9):e1911154. PubMed ID: 31517963
[TBL] [Abstract][Full Text] [Related]
8. Should lymphadenectomy performed routinely in patients with primary intrahepatic cholangiocarcinoma undergoing curative hepatectomy? A retrospective cohort study with propensity-score matching analysis.
Huang S; Song JL; Li B; Yi PS; Yang J
BMC Surg; 2023 Nov; 23(1):364. PubMed ID: 38036995
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
Cercek A; Boerner T; Tan BR; Chou JF; Gönen M; Boucher TM; Hauser HF; Do RKG; Lowery MA; Harding JJ; Varghese AM; Reidy-Lagunes D; Saltz L; Schultz N; Kingham TP; D'Angelica MI; DeMatteo RP; Drebin JA; Allen PJ; Balachandran VP; Lim KH; Sanchez-Vega F; Vachharajani N; Majella Doyle MB; Fields RC; Hawkins WG; Strasberg SM; Chapman WC; Diaz LA; Kemeny NE; Jarnagin WR
JAMA Oncol; 2020 Jan; 6(1):60-67. PubMed ID: 31670750
[TBL] [Abstract][Full Text] [Related]
10. Systemic Chemotherapy with or without Hepatic Arterial Infusion Chemotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Oligometastasis: A Propensity Score-Matched Analysis.
Li Z; Xu R; Chang X; Sun P
J Vasc Interv Radiol; 2024 Mar; 35(3):416-427.e17. PubMed ID: 38008375
[TBL] [Abstract][Full Text] [Related]
11. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
[TBL] [Abstract][Full Text] [Related]
12. Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy.
Buisman FE; Filipe WF; Kemeny NE; Narayan RR; Srouji RM; Balachandran VP; Boerner T; Drebin JA; Jarnagin WR; Kingham TP; Wei AC; Grünhagen DJ; Verhoef C; Koerkamp BG; D'Angelica MI
Ann Surg Oncol; 2021 Feb; 28(2):808-816. PubMed ID: 32648182
[TBL] [Abstract][Full Text] [Related]
13. Systemic chemotherapy plus transarterial chemoembolization versus systemic chemotherapy alone for unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.
Jiang N; Zhang Z; Yin X; Qiu H; Yan W; Hao Y; Yang W; Li H; Xu A; Mu K
Radiol Med; 2024 Apr; 129(4):631-642. PubMed ID: 38355907
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
[TBL] [Abstract][Full Text] [Related]
15. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
Endo I; Gonen M; Yopp AC; Dalal KM; Zhou Q; Klimstra D; D'Angelica M; DeMatteo RP; Fong Y; Schwartz L; Kemeny N; O'Reilly E; Abou-Alfa GK; Shimada H; Blumgart LH; Jarnagin WR
Ann Surg; 2008 Jul; 248(1):84-96. PubMed ID: 18580211
[TBL] [Abstract][Full Text] [Related]
17. Surgery and hepatic artery infusion therapy for intrahepatic cholangiocarcinoma.
Scott A; Wong P; Melstrom LG
Surgery; 2023 Jul; 174(1):113-115. PubMed ID: 36906437
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
20. Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinoma.
Hu LS; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
J Surg Oncol; 2019 Jan; 119(1):21-29. PubMed ID: 30466151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]